Electrical stimulation in psychiatry is still in its infancy. Yet the increasing precision of brain imaging and stimulation ...

Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the "Company” or "Nexalin”) the leader in Deep Intracranial Frequency ...

Nexalin’s method aims to treat substance use disorders by stimulating neural pathways linked to addiction and withdrawal symptoms.

Attorney Jonathan Emord, who has challenged the FDA's approval processes, stated:“All patients who receive ECT suffer memory ...

NIMS Hyderabad offers advanced Parkinson's disease treatment with DBS surgery, improving patient outcomes and quality of life ...

Members of the Our Place Parkinson’s support group learned about a newly approved therapy offering more consistent symptom ...

In recent years, numerous developments have taken place in the field of neuromodulation. The introduction of newer technologies, software and increasing ...

Deep Brain Stimulation therapy is designed to change how brain cells work by giving electrical stimulation to areas of the ...

Nexalin Technology receives US patent for Deep Intracranial Frequency Stimulation technology in treating substance use disorders: Houston, Texas Wednesday, April 16, 2025, 17:00 H ...

Precision meets noninvasive treatment in the revolutionary approach known as focused ultrasound (FUS). Focused ultrasound is a new noninvasive therapeutic approach for people with either Parkinson’s ...

In the intervening years, he tried numerous forms of therapy, medication, brain stimulation, and residential treatments — all ...

AN OPEN-SOURCE AI tool developed by University of Florida researchers, VisionMD, significantly improves the monitoring of ...